Consistently, this SETD7-dependent ferroptosis resistance was also observed in ESCC cells treated with another ferroptosis inducer, Erastin (Fig. 5B and Fig. S2). This evidence concerns the gene SETD7 and esophageal squamous cell carcinoma.